S1798 Real-World Comparison of Infliximab and Adalimumab for Remission Induction in Inflammatory Bowel Disease: A Propensity-Matched Study
Year: 2025
Type: conference-abstract
Authors: Omar Arman, Khaled Rafeh, Laith M. Haj-Ahmad, Husam Abu Suilik, Omar Daas, Noor Arman, Ravneet Kaur, Himaben Gohil, Mazen Zamzam, Jad Bou-Abdallah
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4417195944
Cites:
Cited by:
Related to:
